New Study Shows Impact of COVID-19 and Comorbidities in Inner-City Lung Screening Cohort
In a lung screening cohort of over 2,500 people, researchers found that significantly higher rates of chronic kidney disease and chronic heart failure were associated with increased hospitalization and mortality rates in patients with COVID-19.
Chronic kidney disease (CKD) and/or congestive heart failure (CHF) can lead to significantly higher hospitalization and mortality rates in patients with COVID-19, according to a new study of an inner-city lung cancer screening cohort, which was presented earlier today at the American Roentgen Ray Society (ARRS) conference.
The study involved 2,537 patients from a lung cancer screening program at the Montefiore Medical Center in the Bronx, New York. In a retrospective chart review conducted between March 2020 and June 2021, researchers noted an overall COVID-19 infection rate of 9.1 percent along with a 32 percent hospitalization rate and 6.9 percent mortality rate in patients with COVID-19. Patients hospitalized with COVID-19 had a nearly 20 percent higher incidence rate of CKD (33.8 percent) and a greater than sixfold higher incidence rate of CHF (28.4 percent) in comparison to non-hospitalized patients with COVID-19 (14 percent CKD and 4.5 percent CHF), according to study co-author Linda B. Haramati, MD, MS, a professor in the department of radiology at the Montefiore Medical Center, and colleagues.
Dr. Haramati and colleagues also noted significantly higher rates of chronic obstructive pulmonary disease (COPD), hypertension (HTN), malignancy, and a history of myocardial infraction (MI) among hospitalized patients with COVID-19. Patients with COVID-19-related mortality had a nearly 30 percent higher incidence rate of diabetes (68.8 percent) in comparison to those who survived after COVID-19 infection (39.1 percent), according to the study.
Citing recent socioeconomic statistics, the researchers said that Bronx County, with a poverty rate of 28 percent and a patient-to-clinician ratio of 1,628 to 1, was particularly hard hit during the pandemic. The Bronx had the highest COVID-19-related hospitalization and death rates out of the five boroughs in New York City, according to Dr. Haramati and colleagues.
The study authors conceded study limitations such as drawing data from a single center; database limitations that restricted the availability of comorbidity data to patients with COVID-19; and the possibility of many undocumented COVID-19 infections due to a lack of widespread testing being available during the first wave of the COVID-19 pandemic.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
